Advertisement
Organisation › Details
Molecular Devices LLC
Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics Molecular Devices is committed to the continual development of innovative solutions for life science applications. The Company is headquartered in Silicon Valley with offices around the globe. *
Start | 1983-01-01 established | |
End | 2007-03-28 acquired | |
Group | Danaher (Group) | |
Predecessor | Molecular Devices Inc. | |
Industry | BIOTECH | |
Person | Murphy, Susan (Danaher 202209 President of Molecular Devices) | |
Street | 3860 N First Street | |
City | 95134 San José, CA | |
Address record changed: 2023-11-23 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 186,142,000 (revenues, consolidated (2006) 2006-12-31) | |
Profit | 9,140,000 (2006-12-31) | |
Cash | 22,824,000 (2006-12-31) | |
* Document for »About Section«: | ||
Record changed: 2023-11-26 |
Advertisement
More documents for Danaher (Group)
- [1] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
- [2] Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA....
- [3] faCelliate GmbH. (11/30/22). "Press Release: faCellitate Appoints Christoph Petry, Ph.D. to Become Managing Director and CEO". Mannheim....
- [4] HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA....
- [5] Cevec Pharmaceuticals GmbH. (7/27/21). "Press Release: Cevec Closes Growth Financing Round to Serve Strong Demand in Viral Vector Technologies for Cell and Gene Therapies". Cologne....
- [6] Biognosys AG. (6/15/21). "Press Release: Biognosys Announces New Release of Spectronaut". Schlieren....
- [7] Cytiva. (6/2/21). "Press Release: Cytiva Acquires GoSilico to Strengthen Digital Capabilities in Bioprocessing"....
- [8] Lunaphore Technologies S.A.. (5/13/21). "Press Release: Lunaphore Announces Appointment of Matthias Weber, former President of Leica Biosystems, to Board of Directors". Lausanne....
- [9] Leica Microsystems AG. (3/16/21). "Press Release: Leica Microsystems Acquires Aivia, a Leading AI-enabled 3D Microscopy, Image Visualization and Analysis Software Solution". Wetzlar....
- [10] Cevec Pharmaceuticals GmbH. (2/2/21). "Press Release: Cevec and Carisma Therapeutics Sign License Agreement for the Use of CAP Technology in Anti-tumor Cell Therapies". Cologne & Philadelphia, PA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top